Back to search results

Clinical Study of a Vaginal Cooling Device for Vulvovaginal Candidiasis

This study is testing a vaginal cooling device to treat vulvovaginal candidiasis (VVC), also known as a yeast infection. The device is a medical-grade polymer capsule filled with an inert fluid. Researchers want to see how well this device cures VVC and if it is safe to use. They will measure how many women are clinically cured after 7 days. You may be able to join if you are a woman between 22 and 49 years old, have symptoms of VVC, and can read and understand English. The current status of this study is unclear, and it plans to enroll 55 participants.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 55 women.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The main goal is measured at 7 days (+/-2) after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06983041

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Recruiting
NAAges 22–49InterventionalTreatment
Coologics, Inc
~55 participants
Updated 2026-01-30 on ClinicalTrials.gov
What's tested:vaginal cooling device

At a glance

Recruiting sites
8 of 10 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of clinical cures at 7 days
Measured over 7 days (+/-2)

Conditions

Vulvovaginal Candidiasis (VVC)
Yeast Vaginitis

Explore related trials

Vulvovaginal Candidiasis

NCT06983041

Where you'd take part

This study runs at 10 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Lyndhurst Clinical Research

    Winston-Salem, North Carolinastudy coordinator listed

    Recruiting

  • Next Innovative Clinical Research

    Chicago, Illinoisstudy coordinator listed

    Recruiting

  • Nova Clinical Research

    Miami, Floridastudy coordinator listed

    Recruiting

  • Pivotal Clinical Research & Associates

    Smyrna, Georgiastudy coordinator listed

    Recruiting

  • Renew Health Clinical Research

    Snellville, Georgiastudy coordinator listed

    Recruiting

  • Symphony Clinical Research

    Jacksonville, Floridastudy coordinator listed

    Recruiting

  • Unified Women's Clinical Research-Raleigh

    Raleigh, North Carolinastudy coordinator listed

    Recruiting

  • Vilo Research Group, Inc.

    Houston, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Kimberly J Langdon, MD
[email protected]
740-206-4287
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Number of clinical cures at 7 days7 days (+/-2)

    VSS of 0-1(based on severity of infection), KOH negative for Hyphae